Related references
Note: Only part of the references are listed.Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
Biagio Ricciuti et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
Harriet M. Kluger et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Review of cancer treatment with immune checkpoint inhibitors
Christiane Thallinger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2018)
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long et al.
LANCET ONCOLOGY (2018)
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Michael A. Davies et al.
LANCET ONCOLOGY (2017)
Correlation of Tumor and Peritumoral Edema Volumes with Survival in Patients with Cerebral Metastases
Johannes Kerschbaumer et al.
ANTICANCER RESEARCH (2017)
Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms
Roger Murayi et al.
CHILDS NERVOUS SYSTEM (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
Lucia B. Jilaveanu et al.
CLINICAL CANCER RESEARCH (2015)
TEER Measurement Techniques for In Vitro Barrier Model Systems
Balaji Srinivasan et al.
JALA (2015)
Advances in therapy for melanoma brain metastases
Jaclyn C. Flanigan et al.
CLINICS IN DERMATOLOGY (2013)
Role of the Blood-Brain Barrier in the Formation of Brain Metastases
Imola Wilhelm et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
GBM Volumetry using the 3D Slicer Medical Image Computing Platform
Jan Egger et al.
SCIENTIFIC REPORTS (2013)
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin et al.
LANCET ONCOLOGY (2012)
3D Slicer as an image computing platform for the Quantitative Imaging Network
Andriy Fedorov et al.
MAGNETIC RESONANCE IMAGING (2012)
Transmigration of Melanoma Cells through the Blood-Brain Barrier: Role of Endothelial Tight Junctions and Melanoma-Released Serine Proteases
Csilla Fazakas et al.
PLOS ONE (2011)
Corticosteroids in brain cancer patients: benefits and pitfalls
Jörg Dietrich et al.
Expert Review of Clinical Pharmacology (2011)
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
Elisabetta Dejana et al.
DEVELOPMENTAL CELL (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate
J Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Activation of Stat3 in human melanoma promotes brain metastasis
TX Xie et al.
CANCER RESEARCH (2006)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
Share Paper
